 SAN FRANCISCO, Aug. 10, 2021 GLOBE NEWSWIRE -- Olema Pharmaceuticals, Inc. Olema or Olema Oncology, Nasdaq: OLMA, a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted therapies for womens cancers, today provided an update on recent company developments and reported second quarter financial results for the period ended June 30, 2021. 